BIRC5 and hepatocellular carcinoma: BIRC5, a member of the anti-apoptosis family, mainly exerted its influence on HCC cells in inhibiting apoptosis [30], promoting proliferation [31], enhancing resistance to radiotherapy and chemotherapy [32] and inducing the tumor stromal angiogenesis [33].